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The prognostic significance of vertigo in patients with idiopathic sudden sensorineural hearing 
loss (SSNHL) remains a matter of debate.
Objective: This paper aims to verify the difference between a group with vertigo and a group 
without vertigo, and to analyze vertigo’s validation as a prognostic factor in patients with SSNHL.
Method: This study involved 183 patients with SSNHL. A t-test was used to compare group A (SSNHL 
with vertigo, n = 31) and group B (SSNHL without vertigo, n = 152). Also we want to verify the 
interaction effects between vertigo and other prognostic factors using multiple regression analysis.
Results: There was a significant difference between group A and group B: the initial hearing level 
of group A was lower than group B, and their treatment onset was also shorter. In addition, vertigo 
itself didn’t affect hearing improvement, but the interaction variable between vertigo and initial 
hearing level did affect hearing improvement significantly.
Conclusion: The clinical characteristics of patients with vertigo did not directly affect hearing 
improvement with SSNHL; however, vertigo had an influence on SSNHL though its interaction with 
the initial hearing levels.
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INTRODUCTION
Sudden sensorineural hearing loss (SSNHL) is a loss 
that is greater than 30 dB in three contiguous frequen-
cies and that occurs in less than 3 days1. SSNHL affects 
approximately 5-20 people per population of 100,000. It 
is almost always unilateral and is commonly associated 
with tinnitus and aural fullness. Multiple treatment pro-
tocols and agents have been proposed to treat SSNHL. 
Steroids, antiviral agents, anticoagulants, vasodilators, 
and others have been proposed as therapeutic agents 
to treat SSNHL2-4.
A maximum of 32% to 65% of cases of SSNHL 
may recover spontaneously. Prognosis for recovery is 
dependent on a number of factors, including patient 
age, presence of vertigo at onset, degree of hearing loss, 
audiometric configuration, and time between the onset 
of hearing loss and treatment. Even though some studies 
have reported vertigo as a prognostic factor to SSNHL, it is 
often considered a poor prognostic factor and the effect of 
vertigo as related to SSNHL5-7 is still debated. The reason 
for these inconsistent results is that vertigo is not a specific 
disease, but rather a symptom caused by many different 
etiologies. Although there were some attempts to verify 
the relationship between the results of caloric tests and 
prognoses8-10, the relation between SSNHL and vertigo has 
not been clearly determined.
METHOD
This study used the medical records of 183 patients 
with SSNHL. All patients experienced idiopathic unilate-
ral sensorineural hearing loss that developed within 3 
days and excluded other known pathologies, including 
Meniere’s disease, autoimmune disease, ototoxicity, or 
neoplasm.
The patients had a minimum hearing loss of 30 dB 
at three consecutive frequencies. Patients received steroid 
treatment (injection of prednisolone 60 mg/kg for six days 
then tapered over four days) started concomitantly with 
low molecular weight dextran, and checked 3 months after 
treatment. This study was approved by the institution’s 
Ethics Committee and given permit number EU12-31.
The hearing loss classification was as follows: mild 
(26~40 dB), moderate (41~55 dB), moderately severe 
(56~70 dB), severe (71~90 dB), and profound (over than 
91 dB). The Siegel11 classification was used to evaluate the 
hearing improvement of patients on the last visit, using 
an average gain in four audiometric speech frequencies 
of 500 Hz, 1,000 Hz, 2,000 Hz, and 4,000 Hz.
Patient characteristics and clinical details are given 
in Table 1. In 183 patients (108 female and 75 male) with 
a mean age of 45.11 (± 15.79) years, 152 patients did 
not have vertigo. The degree of hearing loss was relati-
vely evenly distributed: mild (15.8%), moderate (18.0%), 
moderately severe (17.5%), severe (23.0%), and profound 
(25.7%). Treatment onset was distributed: within 3 days 
(161 patients), and over 3 days (22 patients).
Table 1. Demographics and clinical characteristics of the study 
population.
Factors No. (%)
Age
≤ 10 3 (1.6)
11-20 6 (3.3)
21-30 26 (14.2)
31-40 29 (15.8)
41-50 45 (24.6)
51-60 34 (18.6)
≥ 61 40 (21.9)
Vertigo
(+) 31 (16.9)
(-) 152 (83.1)
Treatment onset (days)
≤ 3 161 (88.0)
4-7 15 (8.2)
8-10 3 (1.6)
11-28 3 (1.6)
≥ 29 1 (0.5)
Initial hearing level
Mild 29 (15.8)
Moderate 33 (18.0)
Moderately severe 32 (17.5)
Severe 42 (23.0)
Profound 47 (25.7)
RESULTS
Statistical analyses were carried out with PASW 
Statistics ver. 18.0. A t-test was performed to identify sta-
tistically significant differences between group A (SSNHL 
with vertigo, n = 31) and group B (SSNHL without vertigo, 
n = 152). Multiple regression analysis was used to find 
prognostic factors associated with hearing improvement, 
and analyze the interaction effects of vertigo.
The t-test results revealed that no significant diffe-
rence in SSNHL between the two groups existed; however, 
a significant difference of 0.05 was found in the initial 
hearing level and treatment onset, as shown in Table 2 
and Figure 1.
In addition, multiple regression analysis was used 
to identify predictors of hearing improvement in patient 
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with SSNHL. Treatment onset, initial hearing level, and 
vertigo were used as independent variables while hea-
ring improvement based on Siegel’s classification was 
used as dependent variables. In the regression analysis 
results in Table 3, vertigo was insignificant as a prog-
nostic factor of hearing improvement. Both the treatment 
onset and the initial hearing level were significant at 
0.01. Also, the regression model was accepted at 0.01 
(F = 7.973) and these factors explained 24.2% of the 
variance in SSNHL.
As shown in the results in Table 4, the interac-
tion effect between vertigo and treatment onset was 
invalid. But the interaction effect between vertigo and 
initial hearing level was valid at 0.01. The validation 
was checked as follows: β was identified as significant 
at 0.01, and the R2 of model 2 (0.250) was larger than 
the R2 of model 1 (0.213).
DISCUSSION
This research focused on the prognostic factors 
associated with SSNHL. Initial hearing level, treatment 
onset and vertigo were investigated as prognostic factors. 
We also analyzed the interaction effects of vertigo, which 
was not verified clearly, as a prognostic factor of former 
research.
Firstly, following the comparison results between 
group A (SSNHL with vertigo, n = 31) and group B (SSNHL 
without vertigo, n = 152), initial hearing level and treatment 
onset were significantly different between the two groups 
at the 0.05 level, but SSNHL was insignificant. This result 
supports Ahn et al.12 in proving a significant difference 
between the two groups.
Secondly, from the results of the multiple regres-
sion analysis, initial hearing level and treatment onset 
were significant to hearing improvement while vertigo 
was insignificant. In the former researches, the initial 
hearing level negatively affected SSNHL13, or the initial 
hearing level did not affect SSNHL except in patients 
with profound cases14. Siegel11 showed that there was 
no significant relation between the initial hearing level 
and SSNHL. Our findings added to the research stream 
of Kwon et al.14 and Byl13.
Siegel11 showed that there was no significant 
relation between treatment onset and SSNHL while 
other researchers found that treatment onset affected 
SSNHL14,15. Our research supported the findings that 
treatment onset affected SSNHL significantly (p < 0.01). 
Especially, there were debates over whether vertigo 
was a prognostic factor toward hearing recovery rate. 
Sheehy15 presented that the recovery rate of a patient 
with vertigo was lower than the recovery rate of a pa-
tient in the non-vertigo group. Vertigo decreased the 
hearing improvement rate in the patients with profound 
cases16. Also, Simmons17 hypothesized that vertigo with 
SSNHL may be the result of a membrane break near 
the vestibule. Khetarpal18 studied patients using SSNHL 
and vertigo, and suggested that vertigo may be caused 
Table 2. Results of comparison between with vertigo and 
without vertigo.
Vertigo Means S.D. p-value
Treatment onset
With 1.0645 0.24973
.035**
Without 1.2105 0.63696
Initial hearing level
With 3.7097 1.65718
.046**
Without 3.1513 1.35568
SSNHL
With 2.7742 1.30919
.501
Without 2.5987 1.32355
* p < 0.1; ** p < 0.05; *** p < 0.01.
Figure 1. The difference between with vertigo and without vertigo.
Table 3. Results of regression analysis with vertigo, initial hearing 
level, and treatment onset.
Variables Β F p-value
Vertigo .007 .036 .850
Initial hearing level (IHL) .176 8.600 .000***
Treatment onset (TO) .466 58.946 .000***
* p < 0.1; ** p < 0.05; *** p < 0.01.
We analyzed the interaction effects between 
vertigo and initial hearing (or treatment onset). After 
including interaction variables (Vertigo x TO, Vertigo 
x ITL), we investigated the following equations using 
multiple regression analysis.
Y = α + β1 Vertigo + β2 TO + β3 (Vertigo x TO) + ε: Equation 1
Y = α + β1 Vertigo + β2 ITL + β3 (Vertigo x ITL) + ε: Equation 2
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by biochemical alterations in the inner ear. Kiris et al.19 
presented that between the group with vertigo and the 
group without vertigo there was no difference statisti-
cally. Our research results also supported Kiris et al.19.
Finally, we carried out research to verify the interac-
tion effects between vertigo and other independent variables 
(initial hearing level, treatment onset). The research results 
showed that vertigo did not affect SSNHL directly, but 
we found interaction effects between vertigo and initial 
hearing level. This result supported former studies15,16, and 
clearly showed that vertigo affected hearing improvement 
through interaction with the initial hearing level.
This research has a value to verify that the treat-
ment onset and the initial hearing level affect hearing 
improvement. More important contribution is to find the 
interaction effects of vertigo and initial hearing level to 
predict hearing improvement with SSNHL patients. That 
is, it supports former research studies17,18 only presented 
that vertigo was a significant factor to SSNHL through 
case studies or comparison methods. But, this research 
generalized the vertigo effect of hearing improvement 
with SSNHL statistically using interaction effects method. 
These results will need to be verified through future 
studies.
CONCLUSION
This research analyzed prognostic factors associa-
ted with hearing improvement with SSNHL. A t-test was 
used to compare between group A (SSNHL with vertigo, 
n = 31) and group B (SSNHL without vertigo, n = 152) with 
data from 183 patients, and multiple regression analysis 
was conducted. The results showed that vertigo did not 
directly affect SSNHL. However, there is considerable 
evidence of interaction effects between the initial hearing 
level and vertigo.
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